A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
for Chronic Lymphocytic Leukemia
Sites in Philadelphia +19 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06876649·Phase 4·Recruiting·Listed Mar 2025